Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masayo Sato

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Nephrology|December 22, 2016
Long-term outcomes of initial therapy for idiopathic membranous nephropathyMasayo Sato, Takashi Takei, Takahito Moriyama, et al.
Journal of Bone and Mineral Metabolism|December 26, 2013
The safety and effectiveness profile of daily teriparatide in a prospective observational study in Japanese patients with osteoporosis at high risk for fracture: interim reportTakanori Yamamoto, Masanori Taketsuna, Xiaoyan Guo, et al.
Internal Medicine (Tokyo, Japan)|August 16, 2012
Relation of carotid intima-media thickness and silent cerebral infarction to cardiovascular events and all-cause mortality in chronic hemodialysis patientsMasayo Sato, Tetsuya Ogawa, Himiko Sugimoto, et al.
BMC Health Services Research|December 12, 2007
Validation of a method for identifying nursing home admissions using administrative claimsIlene H Zuckerman, Masayo Sato, Van Doren Hsu, et al.
Archives of Osteoporosis|July 7, 2018
Effect of a patient-support program on once-daily teriparatide adherence and persistence in the Japan Fracture Observational Study (JFOS)Masayo Sato, Mika Tsujimoto, Kenta Kajimoto, et al.
Clinical and Experimental Nephrology|March 30, 2012
Vitamin D receptor agonist supplementation and suppression of inflammation may have advantage for all-cause mortality in hemodialysis patientsTetsuya Ogawa, Ai Kyono, Masayo Sato, et al.
Modern Rheumatology|June 2, 2020
Treatment patterns and health care resource utilization among Japanese patients with ankylosing spondylitis: A hospital claims database analysisTetsuya Tomita, Masayo Sato, Elizabeth Esterberg, et al.
Clinical Interventions in Aging|November 15, 2014
Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)Saeko Fujiwara, Etsuro Hamaya, Masayo Sato, et al.
Neuropsychiatric Disease and Treatment|March 6, 2018
Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetineHideyuki Imagawa, Saurabh P Nagar, William Montgomery, et al.
International Urology and Nephrology|June 29, 2013
Relationship between responsiveness to erythropoiesis-stimulating agent and long-term outcomes in chronic hemodialysis patients: a single-center cohort studyTetsuya Ogawa, Himiko Shimizu, Ai Kyono, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Nephrology|December 22, 2016
Long-term outcomes of initial therapy for idiopathic membranous nephropathyMasayo Sato, Takashi Takei, Takahito Moriyama, et al.
Journal of Bone and Mineral Metabolism|December 26, 2013
The safety and effectiveness profile of daily teriparatide in a prospective observational study in Japanese patients with osteoporosis at high risk for fracture: interim reportTakanori Yamamoto, Masanori Taketsuna, Xiaoyan Guo, et al.
Internal Medicine (Tokyo, Japan)|August 16, 2012
Relation of carotid intima-media thickness and silent cerebral infarction to cardiovascular events and all-cause mortality in chronic hemodialysis patientsMasayo Sato, Tetsuya Ogawa, Himiko Sugimoto, et al.
BMC Health Services Research|December 12, 2007
Validation of a method for identifying nursing home admissions using administrative claimsIlene H Zuckerman, Masayo Sato, Van Doren Hsu, et al.
Archives of Osteoporosis|July 7, 2018
Effect of a patient-support program on once-daily teriparatide adherence and persistence in the Japan Fracture Observational Study (JFOS)Masayo Sato, Mika Tsujimoto, Kenta Kajimoto, et al.
Clinical and Experimental Nephrology|March 30, 2012
Vitamin D receptor agonist supplementation and suppression of inflammation may have advantage for all-cause mortality in hemodialysis patientsTetsuya Ogawa, Ai Kyono, Masayo Sato, et al.
Modern Rheumatology|June 2, 2020
Treatment patterns and health care resource utilization among Japanese patients with ankylosing spondylitis: A hospital claims database analysisTetsuya Tomita, Masayo Sato, Elizabeth Esterberg, et al.
Clinical Interventions in Aging|November 15, 2014
Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)Saeko Fujiwara, Etsuro Hamaya, Masayo Sato, et al.
Neuropsychiatric Disease and Treatment|March 6, 2018
Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetineHideyuki Imagawa, Saurabh P Nagar, William Montgomery, et al.
International Urology and Nephrology|June 29, 2013
Relationship between responsiveness to erythropoiesis-stimulating agent and long-term outcomes in chronic hemodialysis patients: a single-center cohort studyTetsuya Ogawa, Himiko Shimizu, Ai Kyono, et al.
Pageof 7